98%
921
2 minutes
20
Background: Percutaneous nephrolithotomy (PCNL) is the treatment for large and complex renal stones. Fluoroscopic guidance is the most used imaging method; however, radiation exposure is a significant concern. Recent studies have shown that ultrasound-guided PCNL is also feasible.
Objective: To evaluate the safety of the two-step tract dilation technique using ultrasound guidance to avoid radiation exposure.
Material And Methods: Retrospective evaluation of data of patients treated between February 2019 and January 2023. Two groups were included based on tract dilation: Group 1 (G1): two-step totally ultrasound-guided dilation, and group 2 (G2): fluoroscopy-guided dilation.
Results: 100 patients were included, 50 in each group. Body mass index (31.7 vs. 28.7kg/m²; p = 0.002) and stone burden (10,935.69 vs. 5,460.86mm³; p = 0.006) were higher in G1; fluoroscopy was absent in the same group (0 vs. 29.4 sec; p < 0.005). Complications occurred in 13 patients in G1 and in 7 in G2 (p = 0.32); no complications grade 3b, 4 or 5 were observed in either group. The overall stone-free rate was 76% (74% vs. 78%; p = 0.81).
Conclusions: Ultrasound-guided PCNL is a safe technique that avoids radiation exposure without compromising clinical outcomes.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12377859 | PMC |
http://dx.doi.org/10.5281/zenodo.16748335 | DOI Listing |
Urolithiasis
September 2025
Department of Urology, Icahn School of Medicine at Mount Sinai, 424 W. 59th Street, Suite 4F, New York, 10019, United States.
Introduction: High intrarenal pressures (IRP) during mini-PCNL have been postulated to result in increased postoperative pain but no studies have evaluated this to our knowledge. We sought to determine if there is a correlation between IRP and immediate postoperative pain when using different tract sizes.
Methods: Patients were enrolled and assigned for standard (s-PCNL, 24fr), suctioning-mini (sm-PCNL, 16fr) and non-suctioning-mini (nsm-PCNL, 17.
Int J Surg
September 2025
Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
World J Urol
September 2025
Department of Urology, Hospital Clínico San Borja Arriarán, Santiago, Chile.
Purpose: Percutaneous nephrolithotomy (PCNL) is a common technique in the surgical management of renal lithiasis, but it also represents a significant workload for surgeons. Factors such as the patient's position and the type of lithotripter used influence the physical and mental load on the surgeon. The study aimed to identify stressors related to PCNL by comparing the physical and mental workload experienced by urologists during PCNL under different patient positions and using two lithotripters.
View Article and Find Full Text PDFBJUI Compass
September 2025
Department of Urology and Renal Transplantation, Policlinico Riuniti di Foggia University of Foggia Foggia Italy.
Objective: To investigate the incidence, risk factors and clinical consequences of acute kidney injury (AKI) following mini-percutaneous nephrolithotomy (mini-PCNL), with particular focus on its association with postoperative infectious complications.
Materials And Methods: A retrospective analysis was conducted on 496 adult patients who underwent mini-PCNL (22 Ch) between February 2020 and April 2025. AKI was defined according to KDIGO criteria as either a ≥ 1.
Arch Esp Urol
August 2025
Department of Urology and Guangdong Key Laboratory of Urology, First Affiliated Hospital of Guangzhou Medical University, 510230 Guangzhou, Guangdong, China.
Objectives: This study aims to assess the efficacy and safety of five categories of intracorporeal lithotripsy devices in percutaneous nephrolithotomy (PCNL): Pneumatic lithotripters, ultrasonic lithotripters, double-probe dual-energy lithotripters, single-probe dual-energy (SPDE) lithotripters and lasers.
Methods: A network meta-analysis was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. PubMed, Embase and Cochrane were utilised to search for randomised controlled trials (RCTs) up to 10 August 2024.